Prosecution Insights
Last updated: October 02, 2026
Application No. 18/955,657

SURGICAL SYSTEM WITH OFFSET ENERGY SOURCE

Non-Final OA §103§DOUBLEPATENT
Filed
Nov 21, 2024
Priority
Apr 20, 2021 — provisional 63/201,250 +2 more
Examiner
ROANE, AARON F
Art Unit
Tech Center
Assignee
PROCEPT BioRobotics Corporation
OA Round
1 (Non-Final)
73%
Grant Probability
Favorable
1-2
OA Rounds
1y 11m
Est. Remaining
83%
With Interview

Examiner Intelligence

Grants 73% — above average
73%
Career Allowance Rate
657 granted / 895 resolved
+13.4% vs TC avg
Moderate +10% lift
Without
With
+9.7%
Interview Lift
resolved cases with interview
Typical timeline
3y 9m
Avg Prosecution
46 currently pending
Career history
923
Total Applications
across all art units

Statute-Specific Performance

§101
1.6%
-38.4% vs TC avg
§103
46.1%
+6.1% vs TC avg
§102
24.7%
-15.3% vs TC avg
§112
18.1%
-21.9% vs TC avg
Black line = Tech Center average estimate • Based on career data from 895 resolved cases

Office Action

§103 §DOUBLEPATENT
Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Double Patenting The nonstatutory double patenting rejection is based on a judicially created doctrine grounded in public policy (a policy reflected in the statute) so as to prevent the unjustified or improper timewise extension of the “right to exclude” granted by a patent and to prevent possible harassment by multiple assignees. A nonstatutory double patenting rejection is appropriate where the conflicting claims are not identical, but at least one examined application claim is not patentably distinct from the reference claim(s) because the examined application claim is either anticipated by, or would have been obvious over, the reference claim(s). See, e.g., In re Berg, 140 F.3d 1428, 46 USPQ2d 1226 (Fed. Cir. 1998); In re Goodman, 11 F.3d 1046, 29 USPQ2d 2010 (Fed. Cir. 1993); In re Longi, 759 F.2d 887, 225 USPQ 645 (Fed. Cir. 1985); In re Van Ornum, 686 F.2d 937, 214 USPQ 761 (CCPA 1982); In re Vogel, 422 F.2d 438, 164 USPQ 619 (CCPA 1970); In re Thorington, 418 F.2d 528, 163 USPQ 644 (CCPA 1969). A timely filed terminal disclaimer in compliance with 37 CFR 1.321(c) or 1.321(d) may be used to overcome an actual or provisional rejection based on nonstatutory double patenting provided the reference application or patent either is shown to be commonly owned with the examined application, or claims an invention made as a result of activities undertaken within the scope of a joint research agreement. See MPEP § 717.02 for applications subject to examination under the first inventor to file provisions of the AIA as explained in MPEP § 2159. See MPEP § 2146 et seq. for applications not subject to examination under the first inventor to file provisions of the AIA . A terminal disclaimer must be signed in compliance with 37 CFR 1.321(b). The filing of a terminal disclaimer by itself is not a complete reply to a nonstatutory double patenting (NSDP) rejection. A complete reply requires that the terminal disclaimer be accompanied by a reply requesting reconsideration of the prior Office action. Even where the NSDP rejection is provisional the reply must be complete. See MPEP § 804, subsection I.B.1. For a reply to a non-final Office action, see 37 CFR 1.111(a). For a reply to final Office action, see 37 CFR 1.113(c). A request for reconsideration while not provided for in 37 CFR 1.113(c) may be filed after final for consideration. See MPEP §§ 706.07(e) and 714.13. The USPTO Internet website contains terminal disclaimer forms which may be used. Please visit www.uspto.gov/patent/patents-forms. The actual filing date of the application in which the form is filed determines what form (e.g., PTO/SB/25, PTO/SB/26, PTO/AIA /25, or PTO/AIA /26) should be used. A web-based eTerminal Disclaimer may be filled out completely online using web-screens. An eTerminal Disclaimer that meets all requirements is auto-processed and approved immediately upon submission. For more information about eTerminal Disclaimers, refer to www.uspto.gov/patents/apply/applying-online/eterminal-disclaimer. Claims 1-20 are rejected on the ground of nonstatutory double patenting as being unpatentable over claims 1-18 of U.S. Patent No. 12,178,498. Although the claims at issue are not identical, they are not patentably distinct from each other because the present claims are broader than the patented claims with the addition of an extremely well known processor controlled procedure. Claim Rejections - 35 USC § 103 In the event the determination of the status of the application as subject to AIA 35 U.S.C. 102 and 103 (or as subject to pre-AIA 35 U.S.C. 102 and 103) is incorrect, any correction of the statutory basis (i.e., changing from AIA to pre-AIA ) for the rejection will not be considered a new ground of rejection if the prior art relied upon, and the rationale supporting the rejection, would be the same under either status. The following is a quotation of 35 U.S.C. 103 which forms the basis for all obviousness rejections set forth in this Office action: A patent for a claimed invention may not be obtained, notwithstanding that the claimed invention is not identically disclosed as set forth in section 102, if the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains. Patentability shall not be negated by the manner in which the invention was made. Claims 1, 12, 16, and 19 are rejected under 35 U.S.C. 103 as being unpatentable over Dycus et al. (U.S. Patent Application Publication 2004/0254573) in view of Marczyk et al. (U.S. Patent Application Publication 2013/0123783). Regarding claim 1, Dycus et al. disclose a system comprising: an energy source (comprising: 1) “electrically conductive sealing surfaces 112 and 122,” and 2) the reciprocating knife for cutting tissue, see [0027], [0055], [0095], [0099], and figures 8-12); a sheath (“cannula” 510 in figure 36); an elongate shaft (“shaft 12,” see figures 1-4, and 9-12 for example) comprising an elongate axis (the central longitudinal axis), the elongate shaft configured to move the energy source with translation of the elongate shaft along the elongate axis relative to the sheath, the elongate shaft located within the sheath to allow rotation and translation of the energy source relative to the sheath to treat the tissue (see figure 36); and an extension (“upper jaw member 110,” see [0085] and figures 8-10 for example) coupled to the elongate shaft with a link (“pivot pin 103,” see [0091] and figure 8 for example) to rotate the extension about the link to move the energy source away from the elongate axis with movement of the extension away from the elongate axis to offset the energy source from the elongate axis (see figures 1-4, 8-9, and 11-12 for example). Dycus et al. fail to recite a processor operatively coupled to the elongate shaft, the extension and the energy source to rotate and translate the energy source and the extension with the energy source and the extension displaced from the elongate axis. Like Dycus et al., Marczyk et al. disclose an electrical forceps device/system similar to that of Dycus et al. having an energy source, an elongate shaft having an elongate axis, and an extension and a link and teach providing the system with a programmable processor/microprocessor to control the functioning of the electrical forceps device/system in order to provide programmably controlable translational movement of the energy source (knife) and rotatable motion of the energy source (electrically conductive clamping jaw) in order to provide a known and workable system and method for sealing and cutting tissue (see [0023], [0057]-[0058], [0123]-[0125]). Therefore, at the time of the of invention it would have been obvious to one of ordinary skill in the art to modify the invention of Dycus et al., as taught by Marczyk et al., to provide the system with a programmable processor/microprocessor to control the functioning of the electrical forceps device/system in order to provide programmably controlable translational movement of the energy source (knife) and rotatable motion of the energy source (electrically conductive clamping jaw) in order to provide a known and workable system and method for sealing and cutting tissue. Regarding claim 12, Dycus et al. disclose the required stiffness since the sheath does not collapse under compression from the incised tissue opening see figure 36. Regarding claim 16, Dycus et al. disclose electrode (electrically conductive surface 112). Regarding claim 19, Dycus et al. disclose the claimed synchronous movement, wherein synchronous is interpreted as having or being in a definite chronological pattern (i.e., simultaneous or sequential) . Conclusion Any inquiry concerning this communication or earlier communications from the examiner should be directed to AARON F ROANE whose telephone number is (571)272-4771. The examiner can normally be reached generally Mon-Fri 8am-9pm. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Niketa Patel can be reached at (571) 272-4156. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /AARON F ROANE/Primary Examiner, Art Unit 3792
Read full office action

Prosecution Timeline

Nov 21, 2024
Application Filed
Sep 08, 2026
Non-Final Rejection mailed — §103, §DOUBLEPATENT (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12728039
PATIENT INTERFACE DEVICE FOR OPHTHALMIC SURGICAL LASER SYSTEM EMPLOYING A CAP FOR LENS CONE HANDLING
3y 3m to grant Granted Sep 08, 2026
Patent 12728257
THERAPEUTIC ELECTRICAL MUSCLE STIMULATION APPARATUS AND METHOD OF IMPROVING MEDICAL PROCEDURE OUTCOMES
2y 11m to grant Granted Sep 08, 2026
Patent 12708763
WEARABLE SYSTEMS FOR AN ELECTROTHERAPY DEVICE
2y 9m to grant Granted Aug 18, 2026
Patent 12702856
APPARATUS AND METHOD FOR CONTROLLING IMMUNOSTIMULATING LASER THERMOTHERAPY
2y 9m to grant Granted Aug 11, 2026
Patent 12690918
SPECTRAL DETECTION OF OPTICAL FIBER FLASHING EVENT
2y 10m to grant Granted Jul 28, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2
Expected OA Rounds
73%
Grant Probability
83%
With Interview (+9.7%)
3y 9m (~1y 11m remaining)
Median Time to Grant
Low
PTA Risk
Based on 895 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month